OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORASURE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.68+0.07 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $258.18M
- P/E (TTM)
- –
- Dividend yield
- –
ORASURE TECHNOLOGIES INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNAG [Member] | – | – | – | – | – | – | $76.38M | $96.11M | $75.10M | $32.21M | – | – |
| OSUR [Member] | – | – | – | – | – | – | $78.23M | $85.64M | $91.97M | $95.98M | – | – |
| Diagnostics | – | – | – | $303.67M | $90.04M | $65.24M | $78.23M | $85.64M | – | – | – | – |
| Molecular Solutions [Member] | – | – | – | $83.81M | $143.63M | $106.48M | $76.38M | $96.11M | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNAG [Member] | – | – | – | – | – | – | $18.46M | $43.62M | $41.92M | $4.66M | – |
| OSUR [Member] | – | – | – | – | – | – | $154.00K | -$15.19M | -$1.69M | $15.61M | – |
| Diagnostics | – | – | – | -$598.00K | -$57.18M | -$43.16M | $154.00K | -$15.19M | – | – | – |
| Molecular Solutions [Member] | – | – | – | -$22.36M | $47.01M | $37.98M | $18.46M | $43.62M | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products and services | $109.06M | $184.61M | $402.22M | $378.05M | $226.90M | $166.38M | $148.07M | $165.43M | $161.99M | – | 94.8% | -40.9% |
| Other | $5.97M | $1.22M | $3.25M | $9.43M | $6.78M | $5.34M | $6.53M | $16.32M | $5.08M | $21.27M | 5.2% | +390.6% |
| Product [Member] | – | – | – | – | – | – | – | $165.43M | $161.99M | $106.92M | – | – |
| Royalty [Member] | – | – | – | – | – | – | – | $9.65M | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $78.25M | $139.16M | $361.66M | $350.21M | $188.38M | $130.84M | $107.28M | $136.85M | $121.46M | $99.76M | 68.0% | -43.8% |
| Africa | $23.99M | $32.75M | $29.25M | $18.15M | – | – | – | – | – | – | 20.9% | -26.7% |
| Europe | $7.39M | $8.42M | $8.11M | $11.54M | $13.80M | $12.07M | $11.75M | $11.06M | $11.83M | $11.65M | 6.4% | -12.2% |
| Other regions | $5.38M | $5.50M | $6.45M | $7.59M | $31.49M | $28.82M | $35.57M | $33.83M | $33.78M | $16.79M | 4.7% | -2.1% |
From the segment and revenue-disaggregation notes of Orasure Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.